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Abstract
In a time of scientific and technological developments and budgetary constraints, the National 
Cancer Institute (NCI)’s Provocative Questions (PQ) Project offers a novel funding mechanism 
for cancer epidemiologists. We reviewed the purposes underlying the PQ Project, present 
information on the contributions of epidemiologic research to the current PQ portfolio, and outline 
opportunities that the cancer epidemiology community might capitalize on to advance a research 
agenda that spans a translational continuum from scientific discoveries to population health 
impact.
In 2010, Harold Varmus began his stewardship as the director of the National Cancer 
Institute (NCI) with a key initiative called the Provocative Questions (PQ) Project. The 
primary purpose of the PQ Project is to invigorate and “engage a diverse range of scientists 
in a challenging intellectual exercise to define and then solve the major unsolved or 
neglected problems in oncology” (1). The initiative builds on a rich history of scientific 
discoveries and comes at a time of great scientific and technological advances in fields like 
genomics and related disciplines. The NCI’s PQ Project differs from larger global initiatives 
that tend to set overarching goals (e.g., the United Nations’ Millennium Development Goals) 
or post challenges (e.g., Gates Foundation’s Grand Challenges in Global Health) (1). 
Instead, this NCI initiative identifies and funds the search for answers to specific scientific 
questions, reflecting the belief that addressing specific and intractable problems can inspire 
the most outstanding work in science.
Towards this effort to identify important but unanswered scientific questions, the NCI 
launched the Provocative Questions Project website (2) and gathered questions from the 
cancer research community. Concurrently, in a series of workshops across the country, an 
assembled group of scientific leaders deliberated on potential questions and selected 24 PQ 
questions to provide the basis of the PQ’s Funding Opportunity Announcements (FOAs) (3) 
in October 2011. As noted on the website, these questions do not represent the scope of 
NCI’s priorities in cancer research, but serve to probe and challenge cancer researchers to 
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Contemporaneous with the introduction of the PQ Project, an independent undercurrent of 
thought-provoking publications appeared. These publications simultaneously call for a 
reexamination of priorities and strategic approaches across different health-related 
disciplines as the conduct of scientific research (and thinking) must adapt quickly to an 
evolving technological, demographic, and budgetary landscape. For example, in their essay 
on 21st century public health, Lang and Rayner lamented the need to revamp the practice of 
public health and alter the public’s misconception of the field by reminding the audience of 
the inter-relationship between health and societal progress (4). Furthermore, they advocated 
for the embracement of ecological public health as essential to progress instead of its 
abandonment or neglect in times of economic hardships (4). Coincidentally, epidemiology, a 
discipline at the heart of public health, is undergoing a similar rethinking. The field, opined 
Michael Lauer, Director of the Division of Cardiovascular Sciences of the National Heart, 
Lung, and Blood Institute, is in need of a “creative transformation” to include refocused 
scientific questions, incorporation of technologies, centralized governance, cross-discipline 
collaboration, and clinical trials embedded in registries (5). In tandem, the Epidemiology 
and Genomics Research Program (EGRP) at NCI led a strategic planning “longitudinal” 
meeting, Trends in 21st Century Epidemiology: From Scientific Discoveries to Population 
Health Impact in December 2012 to invigorate 21st century epidemiologists (6, 7). From the 
NCI’s Workshop, several recommendations emerged for the epidemiology community to 
consider. These recommendations, published elsewhere in this special edition (see Khoury et 
al 2013), include (i) extending the reach of epidemiology beyond discovery and etiologic 
research to include interdisciplinary/ multilevel evaluation, implementation, and outcomes 
research; (ii) transforming the practice of epidemiology by moving towards more access and 
sharing of protocols, data, metadata, and specimens to foster collaboration, to ensure 
reproducibility and replication, and accelerate translation; (iii) expanding cohort studies to 
collect exposure, clinical and other information across the life course and examining 
multiple health-related endpoints; (iv) developing and validating reliable methods and 
technologies to quantify exposures and outcomes on a massive scale, and to assess 
concomitantly the role of multiple factors in complex diseases; (v) integrating “big data” 
science into the practice of epidemiology; (vi) expanding knowledge integration to drive 
research, policy and practice; (vii) transforming training of 21st century epidemiologists to 
address interdisciplinary and translational research; and (viii) optimizing the use of 
resources and infrastructure for epidemiologic studies. Echoing across these intellectual 
discourses is a concerted exhortation for adaptation of changes (e.g. disruptive technologies) 
and optimizing resources to evolve constructively and ensure relevance and continued 
contribution to society.
The current fiscal constraints for funding scientific research, however, dampens enthusiasm 
for the translation of these ideas into actions as budgetary constraints act as a major 
disincentive for expanding or extending research. Nevertheless, a resource-scarce 
environment necessitates greater resourcefulness and innovation. Although receiving less 
attention, the PQ Project’s second purpose is to experiment with an innovative funding 
mechanism that permits investigators to “propose intriguing questions in cancer research 
that need attention but would usually find it difficult to get” (1). In the initial FOAs, $17 
million were dedicated to fund awarded PQ proposals. The NCI received approximately 750 
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applications in response to the PQ’s Request For Applications (RFAs). In reaction to this 
overwhelming response from the scientific community, the Fiscal Year (FY) 2012 budget 
dedicated to funding PQ projects increased to $22 million.
While the PQ Project does not focus on particular scientific disciplines, Dr. Varmus and the 
NCI leadership recognized the contributions of epidemiology in cancer. In a 2011 town hall 
meeting (8), Dr. Varmus stated, “I expect to see a pretty dramatic revolution in 
epidemiology... defining cancers by genetic subsets. I expect to see molecular tools brought 
more forcefully into the realm of cancer diagnosis... talking about ways to discriminate 
among early lesions and pre-cancerous lesions that may have malignant potential.” (9). 
Examination of the PQ applications received in response to the initial RFAs revealed that 
there was an underrepresentation of applications submitted that were epidemiologic in 
nature. For the purpose of this commentary, we broadly defined epidemiologic research as 
research conducted on human populations to understand determinants of cancer occurrence 
and outcomes. Of the total 748 applications, only 40 (5%) of the applications were from 
population scientists and referred to the NCI’s Division of Cancer Control and Population 
Sciences (DCCPS), Figure 1. These statistics are grossly lower than the typical number of 
applications received by NCI and referred to DCCPS annually. For example in FY 2012, 
NCI received 10,448 competing applications for funding, and approximately 14% (N= 
1,509) were related to population sciences and referred to DCCPS. This suggests that cancer 
epidemiologists might not have fully capitalized on this new funding mechanism and 
opportunity.
The success rate for funding of epidemiology-related PQ proposals was slightly higher 
comparatively to the proportion of applications. The NCI awarded 57 applicants whose 
research individually sought to answer one of the 24 provocative questions. Population 
sciences research represented 9% (N=5) of the 57 awarded applications (Figure 1). The 
majority of the PQ applications referred to DCCPS were responding to three PQ questions: 
(1) How does obesity contribute to cancer risk? (PQ-1); (2) What environmental factors 
change the risk of various cancers when people move from one geographic region to 
another? (PQ-2); and (3) Why don’t more people alter behaviors known to increase the risk 
of cancers? (PQ-4). Successful PQ epidemiology-related proposals reflected this distribution 
(Figure 1).
Some of the remaining 21 PQs posed could have leveraged epidemiologic methods; 
unfortunately, these received very few applications from population scientists. Several 
reasons may explain the lackluster number of PQ applications from the cancer epidemiology 
community. Population-based research is costly and it is conceivable that the original 
funding allocated for the PQ Project may have deterred some epidemiologists from 
applying. However, as mentioned earlier, the NCI leadership devoted more funding to the 
initial round to fund additional meritorious PQ proposals.
Another reason for the lower number of epidemiologic applications may be that the 24 
provocative questions originally identified may have been viewed as skewed heavily 
towards basic science and thus leaving a narrow opportunity for applications that uses 
epidemiologic concepts and methods to answer the questions. The reach and application of 
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epidemiology should not be narrowed by this misperception. Epidemiology is circular by 
nature—findings can inform bench science which informs epidemiology and further 
downstream can influence translation of findings into policy and guidelines. As a central 
infrastructure, epidemiologic concepts and methods can be leveraged to address some of the 
basic science questions such as those in the PQs. Extending the boundaries of epidemiology 
as recommended by the NCI Workshop (see Khoury et al 2013) requires creativity, 
provocativeness, resourcefulness, and collaboration across disciplines. Proposals to integrate 
basic or clinical studies within the framework of traditional epidemiologic studies, for 
example, could be submitted. Alternatively, epidemiologists can modify or adapt the current 
PQs to develop proposals with a more population approach or gauge the programmatic 
interests based on the questions to generate new research ideas. These proposals can be 
submitted under the omnibus investigator-initiated FOAs (10). Lastly, the PQ Project is a 
dynamic initiative in which provocative questions are continually being developed.
Over the past year, NCI updated the original set of 24 PQs. The revised 24 PQs are 
categorized into four groups (Group A to Group D) based on PQ theme (Table 1). For 
example, Group A consists of six questions related to cancer prevention and risk while 
Group D’s questions relate to cancer therapy and outcomes. Cancer epidemiologists should 
think more broadly across the translational research continuum when reviewing the revised 
set of PQs as well as their research objectives. Collaborations between basic, clinical and 
population scientists, for example, can extend the boundaries of traditional epidemiology to 
help unravel the answers to some of the PQs. Illustratively, the answer or answers to PQD3 
“What underlying causal events - e.g., genetic, epigenetic, biologic, behavioral, or 
environmental - allow certain individuals to survive beyond the expected limits of otherwise 
highly lethal cancers?” may benefit from such a trans/multi-disciplinary collaboration. New 
approaches like integrative epidemiology, as advocated by Spitz et al (11), can be applied to 
explore the mechanistic underpinnings of epidemiologic observations in cancer risk and 
outcomes.
For the current PQ process, NCI has issued eight FOAs, utilizing the RO1 (N=4) and R21 
(N=4) funding mechanisms (12). The scientific scope of the application must correspond to 
one and only one PQ in the group (Table 1). The next deadline for response to RFAs relating 
to the PQ Project is in May 2013. We encourage epidemiologists to collaborate with their 
basic science and clinical colleagues to take full advantage of this funding mechanism. 
Development of provocative questions for 2014 is underway, which may include new 
population science questions. Investigators should stay alert for subsequent PQ 
announcements.
Cancer epidemiology is at the cusp of a paradigm shift and several “drivers” have been 
influencing the field in the near decades (7). The drivers include: (i) collaboration and team 
science; (ii) methods and technologies; (iii) multi-level analyses and interventions; and (iv) 
knowledge integration from basic, clinical and population sciences (7). The PQ Project is 
one vehicle to enable the incorporation of these drivers into cancer epidemiologic research 
and part of a collective and fluid movement towards a transformation in health research. The 
provocativeness lies not only in the scientific questions, but also in the resourcefulness of 
the investigators to seize funding opportunities and to think in creative and transformative 
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ways to get to answers that can have an impact on reducing the burden of cancer in 
populations.
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Applications received from the initial announcement of the PQ Project that were referred to 
and funded by the NCI, Division on Cancer Control and Population Sciences (DCPPS)
NOTE: The PQs from the initial announcement can be found at: http://
provocativequestions.nci.nih.gov/rfa-archive
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